Westphal Martin, Stubbe Henning, Sielenkämper Andreas W, Ball Christian, Van Aken Hugo, Borgulya Reka, Bone Hans-Georg
Department of Anaesthesiology and Intensive Care, University of Muenster, Germany.
Crit Care Med. 2003 May;31(5):1502-8. doi: 10.1097/01.CCM.0000063042.15272.84.
To determine the effects of titrated arginine vasopressin (AVP) alone or in combination with norepinephrine (NE) on hemodynamics and oxygen transport in healthy and endotoxemic sheep.
Prospective controlled trial.
University research laboratory.
Six adult ewes.
Healthy sheep received AVP as a titrated infusion, initiated with 0.6 units/hr and increased by 0.6 units/hr every 15 mins, either until mean arterial pressure was increased by 20 mm Hg vs. baseline or a maximum of 3.6 units/hr was administered. After 90 mins, AVP infusion was continued with the investigated dosage, and NE (0.2 microg x kg(-1) x min(-1)) was also infused for 90 mins. After a 24-hr period of recovery, endotoxemia was induced and maintained (Salmonella typhosa endotoxin, 10 ng x kg(-1) x min(-1)) in the same sheep for the next 19 hrs. After 16 hrs of endotoxemia, AVP and NE were administered as described previously.
Hemodynamics were obtained at baseline, every 15 mins during the titration period, and 60 and 90 mins after additional NE infusion. Variables of oxygen transport were calculated before and after the titration period. In healthy and endotoxemic sheep, AVP reduced heart rate and cardiac index (p <.001) and compromised oxygen delivery (p <.001) and oxygen consumption (healthy sheep, p =.003; endotoxemic sheep, p <.001). Vasopressin infusion did not alter mean pulmonary arterial pressure but increased pulmonary vascular resistance index in both groups (p <.001). Additional infusion of NE further augmented mean arterial pressure and increased cardiac index during endotoxemia (p <.001). This was accompanied by an increase in oxygen delivery and consumption (p <.05 each).
During ovine endotoxemia, AVP decreased cardiac index, compromised oxygen delivery, and increased pulmonary vascular resistance index. These side effects may limit its use as a sole vasopressor during sepsis. Potentially, a simultaneous infusion of AVP and NE could represent a useful therapeutic option.
确定滴定剂量的精氨酸加压素(AVP)单独使用或与去甲肾上腺素(NE)联合使用对健康和内毒素血症绵羊血流动力学和氧输送的影响。
前瞻性对照试验。
大学研究实验室。
6只成年母羊。
健康绵羊接受滴定剂量的AVP静脉输注,起始剂量为0.6单位/小时,每15分钟增加0.6单位/小时,直至平均动脉压较基线升高20 mmHg,或最大剂量达到3.6单位/小时。90分钟后,继续以研究剂量输注AVP,并同时输注NE(0.2微克·千克⁻¹·分钟⁻¹)90分钟。经过24小时的恢复后,诱导并维持绵羊内毒素血症(伤寒沙门氏菌内毒素,10纳克·千克⁻¹·分钟⁻¹)19小时。内毒素血症16小时后,按上述方法给予AVP和NE。
在基线、滴定期间每15分钟以及额外输注NE后60和90分钟时获取血流动力学数据。在滴定前后计算氧输送变量。在健康和内毒素血症绵羊中,AVP降低心率和心脏指数(p <.001),损害氧输送(p <.001)和氧消耗(健康绵羊,p =.003;内毒素血症绵羊,p <.001)。输注加压素未改变平均肺动脉压,但两组的肺血管阻力指数均增加(p <.001)。在内毒素血症期间额外输注NE进一步升高平均动脉压并增加心脏指数(p <.001)。同时伴有氧输送和消耗增加(均p <.05)。
在绵羊内毒素血症期间,AVP降低心脏指数,损害氧输送,并增加肺血管阻力指数。这些副作用可能限制其在脓毒症期间作为单一血管升压药的使用。AVP和NE同时输注可能是一种有用的治疗选择。